Putnam Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-203,338
| Closed | -$8M | – | 1240 |
|
|
2023
Q2 | $8M | Sell |
203,338
-354,456
| -64% | -$12.5M | 0.01% | 354 |
|
|
2023
Q1 | $13.6M | Buy |
557,794
+180,885
| +48% | +$3.96M | 0.02% | 264 |
|
|
2022
Q4 | $8.07M | Buy |
376,909
+232,209
| +160% | +$4.96M | 0.01% | 336 |
|
|
2022
Q3 | $2.6M | Buy |
144,700
+127,698
| +751% | +$1.68M | ﹤0.01% | 685 |
|
|
2022
Q2 | $164K | Buy |
+17,002
| New | +$213K | ﹤0.01% | 1115 |
|
|
2022
Q1 | – | Sell |
-114,582
| Closed | -$1.92M | – | 1291 |
|
|
2021
Q4 | $1.92M | Buy |
+114,582
| New | +$1.88M | ﹤0.01% | 766 |
|
|
2016
Q4 | – | Sell |
-36,861
| Closed | -$1.7M | – | 1302 |
|
|
2016
Q3 | $1.7M | Sell |
36,861
-25,766
| -41% | -$1.45M | ﹤0.01% | 892 |
|
|
2016
Q2 | $3.2M | Buy |
62,627
+19,393
| +45% | +$964K | 0.01% | 798 |
|
|
2016
Q1 | $1.83M | Buy |
43,234
+903
| +2% | +$46K | ﹤0.01% | 972 |
|
|
2015
Q4 | $3.32M | Sell |
42,331
-765
| -2% | -$44.2K | 0.01% | 815 |
|
|
2015
Q3 | $1.75M | Buy |
43,096
+1,167
| +3% | +$61.8K | ﹤0.01% | 1027 |
|
|
2015
Q2 | $2.18M | Buy |
+41,929
| New | +$2.09M | ﹤0.01% | 1031 |
|
Putnam Investments's ISEE Position: Q3 2023 in Review
Putnam Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 203,338 shares — an estimated $8M sold.
Putnam Investments first reported a position in ISEE in Q2 2015 and held it in 12 quarters. The position peaked at $13.6M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Putnam Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Putnam Investments sold 203,338 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $8M.
- Putnam Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 12 quarters.
- Putnam Investments's IVERIC bio, Inc. Common Stock position peaked at $13.6M in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Putnam Investments's 13F filing for Q3 2023, filed 14 Nov 2023.